Tower Research Capital LLC (Trc) Fennec Pharmaceuticals Inc. Transaction History

Tower Research Capital LLC (Trc)

$3.68 Billion
Q3 2024

A detailed history of Tower Research Capital LLC (Trc) transactions in Fennec Pharmaceuticals Inc. stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 2,449 shares of FENC stock, worth $15,918. This represents 0.0% of its overall portfolio holdings.

Number of Shares

2,449

Previous 4,547 46.14%

Holding current value

$15,918

Previous $27,000 55.56%

% of portfolio

0.0%

Previous 0.0%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$4.85 - $6.73 $10,175 - $14,119	-2,098 Reduced 46.14%	2,449 $12,000
Q2 2024 Aug 13, 2024	BUY	$6.02 - $10.99 $25,025 - $45,685	4,157 Added 1065.9%	4,547 $27,000
Q1 2024 May 15, 2024	SELL	$8.82 - $11.12 $23,443 - $29,556	-2,658 Reduced 87.2%	390 $4,000
Q4 2023 Feb 13, 2024	BUY	$6.48 - $11.61 $10,225 - $18,320	1,578 Added 107.35%	3,048 $34,000
Q3 2023 Nov 14, 2023	BUY	$7.15 - $8.94 $6,034 - $7,545	844 Added 134.82%	1,470 $11,000
Q2 2023 Aug 14, 2023	SELL	$7.27 - $9.82 $18,116 - $24,471	-2,492 Reduced 79.92%	626 $5,000
Q1 2023 May 09, 2023	BUY	$7.38 - $10.35 $191 - $269	26 Added 0.84%	3,118 $26,000
Q4 2022 Feb 10, 2023	SELL	$7.63 - $10.22 $3,959 - $5,304	-519 Reduced 14.37%	3,092 $29,000
Q3 2022 Nov 10, 2022	SELL	$5.71 - $8.54 $2,089 - $3,125	-366 Reduced 9.2%	3,611 $29,000
Q2 2022 Aug 15, 2022	BUY	$5.17 - $6.33 $19,847 - $24,300	3,839 Added 2781.88%	3,977 $23,000
Q1 2022 May 12, 2022	SELL	$4.29 - $6.08 $25,019 - $35,458	-5,832 Reduced 97.69%	138 $1,000
Q4 2021 Feb 14, 2022	BUY	$3.89 - $10.01 $23,223 - $59,759	5,970 New	5,970 $26,000
Q2 2021 Aug 16, 2021	SELL	$5.96 - $7.85 $30,247 - $39,838	-5,075 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$6.21 - $8.68 $1,273 - $1,779	205 Added 4.21%	5,075 $31,000
Q4 2020 Feb 16, 2021	SELL	$5.99 - $8.55 $95,462 - $136,261	-15,937 Reduced 76.59%	4,870 $36,000
Q3 2020 Nov 16, 2020	BUY	$5.19 - $10.17 $101,884 - $199,647	19,631 Added 1669.3%	20,807 $126,000
Q2 2020 Aug 13, 2020	BUY	$5.43 - $9.39 $6,385 - $11,042	1,176 New	1,176 $10,000
Q1 2020 May 15, 2020	SELL	$4.89 - $8.1 $5,687 - $9,420	-1,163 Closed	0 $0
Q4 2019 Feb 07, 2020	BUY	$4.25 - $6.49 $3,200 - $4,886	753 Added 183.66%	1,163 $7,000
Q3 2019 Nov 05, 2019	BUY	$3.85 - $4.95 $1,578 - $2,029	410 New	410 $2,000
Q2 2019 Aug 13, 2019	SELL	$3.3 - $5.09 $11,589 - $17,876	-3,512 Closed	0 $0
Q1 2019 May 14, 2019	BUY	$4.64 - $7.58 $16,295 - $26,620	3,512 New	3,512 $17,000
Q4 2018 Feb 14, 2019	SELL	$5.37 - $8.39 $1,670 - $2,609	-311 Closed	0 $0
Q3 2018 Nov 13, 2018	BUY	$7.84 - $10.83 $2,438 - $3,368	311 New	311 $3,000
Q2 2018 Aug 15, 2018	SELL	$10.05 - $14.33 $824 - $1,175	-82 Closed	0 $0
Q1 2018 May 15, 2018	SELL	$8.26 - $12.1 $8,334 - $12,208	-1,009 Reduced 92.48%	82 $1,000
Q4 2017 Feb 09, 2018	BUY	$8.9 - $12.35 $6,149 - $8,533	691 Added 172.75%	1,091 $14,000
Q3 2017 Nov 14, 2017	BUY	$11.09 - $12.0 $4,436 - $4,800	400	400 $4,000

Others Institutions Holding FENC

# of Institutions

Shares Held

14.8M

Call Options Held

10K

Put Options Held

83.8K

View Full List

About FENNEC PHARMACEUTICALS INC.

Ticker FENC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 26,067,300
Market Cap $169M
Description
Fennec Pharmaceuticals Inc. operates as a biopharmaceutical company. Its product candidate in the clinical stage of development is PEDMARK, a formulation of sodium thiosulfate for the prevention of platinum-induced ototoxicity in pediatric cancer patients. The company was formerly known as Adherex Technologies Inc. and changed its name to Fennec...

More about FENC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

News

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.

Account

Tower Research Capital LLC (Trc) Fennec Pharmaceuticals Inc. Transaction History